Navigating the acquisition of specialized autocrine regulators requires strict compliance with analytical purity, verified sequence identity, and robust quality control. Principal investigators looking to bestellen Follistatin peptide for laboratory research demand fully characterized reagents backed by lot-specific documentation and low endotoxin thresholds. PX1 Research supplies high-purity research peptides engineered exclusively for in vitro assay systems and preclinical investigation.
Navigating the acquisition of specialized autocrine regulators requires strict compliance with analytical purity, verified sequence identity, and robust quality control. Principal investigators looking to bestellen Follistatin peptide for laboratory research demand fully characterized reagents backed by lot-specific documentation and low endotoxin thresholds. PX1 Research supplies high-purity research peptides engineered exclusively for in vitro assay systems and preclinical investigation.
To bestellen Follistatin peptide for scientific inquiry, research institutions must select qualified chemical suppliers that provide comprehensive lot verification, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) documentation. Follistatin is an autocrine glycoprotein that functions as a potent antagonist to transforming growth factor-beta (TGF-β) superfamily ligands, particularly activin and myostatin (GDF-8). Sourcing high-grade material ensures experimental reproducibility in preclinical cellular and tissue models.
When procurement officers and laboratory managers seek to order these reagents, evaluating the manufacturing pipeline is essential. Research-grade Follistatin must be synthesized under stringent quality management protocols to prevent batch-to-batch variation, baseline degradation, or contamination with bacterial endotoxins. Utilizing an established USA-based source ensures immediate access to verified certificates of analysis (COA) and reliable cold-chain logistics tailored for experimental workflows.
Follistatin is a naturally occurring monomeric peptide derived from a single gene, existing in multiple isoform variants due to alternative splicing and post-translational modifications. The primary variants investigated in laboratory settings include Follistatin-288, Follistatin-300, and Follistatin 344. Structurally, the molecule contains a cysteine-rich domain architecture comprising an N-terminal domain followed by three follistatin domains (FS1, FS2, and FS3), which facilitate high-affinity binding to target ligands.
The primary biochemical function of Follistatin revolves around its capacity to sequester specific members of the TGF-β superfamily. By binding with high affinity to activins A and B, as well as myostatin, Follistatin physically blocks these ligands from engaging their cognate cell-surface receptors, such as Activin Type II receptors (ActRIIA and ActRIIB). In vitro assays demonstrate that this sequestration prevents downstream intracellular phosphorylation of SMAD2 and SMAD3 transcription factors, effectively suppressing target gene expression responsible for cellular differentiation or growth arrest.
Academic interest in Follistatin centers largely on its regulatory influence over muscular hypertrophy, adipose tissue conversion, and reproductive tissue physiology. In rodent models of muscle wasting, preclinical studies suggest that administration of recombinant Follistatin results in a marked attenuation of myostatin signaling, leading to increased cross-sectional muscle fiber area and enhanced satellite cell activation. Researchers utilize these models to explore fundamental pathways governing protein synthesis and degradation balance.
Beyond skeletal muscle research, in vitro data indicate that Follistatin plays a critical role in cellular proliferation assays, reproductive endocrinology research, and fibrotic pathway modulation. Because activin signals participate in inflammatory cascades and extracellular matrix deposition, blocking activin signaling via Follistatin provides valuable insights into tissue repair dynamics. Exploring these mechanisms through our PX1 research library allows investigator teams to design robust control assays when mapping out growth factor signaling pathways.
When designing comparative experimental matrices, investigators frequently examine Follistatin alongside other peptides targeting metabolic, anabolic, or repair cascades. Understanding how distinct peptide classes interact with receptor networks allows researchers to formulate multi-arm assay protocols.
In studies targeting muscle architecture and metabolic regulation, Follistatin is often analyzed parallel to compounds acting through distinct receptor pathways. For instance, while Follistatin acts via direct ligand neutralization of myostatin, IGF-1 LR3 modulates cellular growth by engaging the receptor tyrosine kinase IGF-1R, initiating the PI3K/Akt intracellular cascade. Concurrently, researchers studying tissue preservation and extracellular matrix regeneration frequently incorporate BPC-157 to evaluate vascularization pathways, comparing these outputs against the anti-fibrotic parameters observed during activin inhibition. Exploring these distinct profiles within our complete catalog of research peptides enables comprehensive experimental design.
Securing reliable data in cellular research requires reagents of absolute purity. When searching to bestellen Follistatin peptide, relying on basic claims of high purity is insufficient. Academic laboratories must inspect the lot-specific Certificate of Analysis (COA) generated by an independent, ISO 17025 accredited laboratory.
Analytical verification of Follistatin requires two essential testing methods. First, Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) measures chemical purity, ensuring that related peptide impurities or truncated sequences do not exceed strict baseline tolerances. Second, Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF confirms exact molecular weight, verifying sequence identity. At PX1 Research, every production lot undergoes rigorous dual-method validation to guarantee high consistency before release.
Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative cell walls—present a significant confounding variable in cell culture and animal tissue assays. High endotoxin levels induce non-specific inflammatory responses in vitro, masking true receptor binding mechanics and invalidating experimental results.
PX1 Research enforces strict bioburden control during peptide synthesis and purification. Each lot of Follistatin undergoes quantitative Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing to verify that endotoxin content remains well below established research thresholds (typically < 0.1 EU/µg). Operating out of GMP-compliant synthesis facilities, we ensure that the physical reagents supplied meet stringent standards required for delicate cell culture and microfluidic research platforms.
Lyophilized Follistatin peptide requires precise handling to preserve tertiary structure and bioactivity upon fluid preparation. Upon receiving the lyophilized cake, vials should be equilibrated to room temperature in a desiccator before reconstitution to prevent condensation entrapment inside the vial.
For standard laboratory assays, reconstitution should be performed using sterile, non-pyrogenic Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream application. The solvent should be introduced gently along the glass wall of the vial, followed by low-speed swirling or gentle inversion. High-shear mechanical vortexing must be strictly avoided, as it can cause peptide denaturation or aggregation of complex protein structures.
Proper temperature control is critical to preventing hydrolysis, oxidation, or peptide cleavage over extended storage periods. In its lyophilized state, Follistatin peptide maintains stability when stored at -20°C or -80°C in a manual defrost freezer, protected from light exposure.
Once reconstituted into solution, aliquots should be prepared immediately using low-protein-binding microcentrifuge tubes to prevent adsorption loss onto container surfaces. Working reconstituted solutions stored at 2°C to 8°C should be utilized within a short timeframe, while long-term storage of reconstituted aliquots requires deep freezing at -80°C. Freeze-thaw cycles must be rigorously minimized, as repeated phase changes promote protein aggregation and irreversible loss of binding capacity.
Minimizing transit times and maintaining thermal integrity during delivery are essential factors when laboratory staff decide to bestellen Follistatin peptide. Procurement delays or international customs holds can expose temperature-sensitive peptides to elevated ambient temperatures, risking degradation.
PX1 Research manufactures all research compounds within the United States, dispatching orders directly from centralized distribution facilities in California and Arizona. Orders placed Monday through Friday ship same-day, utilizing dedicated packaging designed to protect product integrity. Principal investigators establishing high-volume assay screens can set up a direct bulk lab procurement account to streamline scheduled fulfillment, ensuring uninterrupted reagent supply for long-term study protocols.
What is the primary mechanism of Follistatin in preclinical research?
In preclinical research, Follistatin functions primarily as an autocrine binding protein that neutralizes TGF-beta superfamily ligands, including activin and myostatin (GDF-8), preventing them from interacting with cell-surface Activin Type II receptors.
How is product purity verified before I bestellen Follistatin peptide?
Every lot of Follistatin from PX1 Research undergoes third-party verification via RP-HPLC to measure chemical purity (>98%) and Mass Spectrometry (MS) to confirm molecular weight and sequence identity. Lot-specific COAs are fully accessible.
What are the endotoxin limits for PX1 Research peptides?
PX1 Research peptides are tested using quantitative LAL assays to ensure endotoxin levels remain below stringent research-grade limits (typically < 0.1 EU/µg), preventing confounding inflammatory responses in cell culture models.
What solvent should be used for reconstituting Follistatin in laboratory assays?
Reconstitution is typically performed using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the specific buffer compatibility required by the downstream in vitro protocol.
How should lyophilized Follistatin be stored upon arrival?
Lyophilized Follistatin should be stored at -20°C or -80°C in a dry environment, protected from light. Reconstituted aliquots should be frozen at -80°C to avoid degradation from freeze-thaw cycles.
What is the difference between Follistatin 344 and other isoforms?
Follistatin 344 is a precursor isoform that undergoes processing to yield circulating and tissue-bound forms. In research, it is studied for its systemic clearance profile and potent tissue-binding dynamics relative to shorter isoforms like FS-288.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona with same-day dispatch for orders placed M–F.
Are PX1 Research compounds suitable for human or therapeutic use?
No. All compounds supplied by PX1 Research are intended strictly for laboratory research, in vitro assays, and preclinical investigation. They are not for human consumption, clinical diagnostic, or therapeutic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.